Buzzworthy developments of the past few days.

AI won’t fulfill its promise to transform American medicine if it isn’t appropriately integrated, step by step, across U.S. healthcare.

Delaying TAVR in eligible patients with severe AS can lead to much higher healthcare costs, according to a new study of real-world Medicare data.

Cardiovascular Associates of America, backed by Webster Equity Partners, currently includes practices in eight different states. Its partner cardiologists now have preferred access to multiple cloud-based services provided by Athenahealth. 

Peter Monteleone, MD, national director of cardiovascular research at Ascension Health, explains the growing role of interventional cardiology in pulmonary embolism treatment and PERT teams.

Buzzworthy developments of the past few days.

AI transparency in medical devices is achievable and imperative, according to new guidance jointly promoted by the FDA, Health Canada and the U.K.’s Medicines and Healthcare products Regulatory Agency.

The past five years have been boom times for AI startups courting venture investors in healthcare, and the good times just keep rolling.